ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentPfäffikon SzLamKap Bio alpha AG
LamKap Bio alpha AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

LamKap Bio alpha AG is a LamKap Bio group program that researches, develops and manufactures fully human bispecific antibodies for the treatment of solid tumours. The approach redirects patients' immune effector cells (macrophages, T cells and natural killer cells) to target cancer cells; the pipeline includes candidates with target combinations such as CEA×CD3, CEA×CD28 and CEA×CD47.

AI-generated
Offering

Products & services

Industry:Research & Development
✓ Offered
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

LamKap Bio alpha AG

3
Development of bispecific antibodies for cancer
Fully human bispecific antibodies for cancer treatment in discovery and preclinical development, including T-cell retargeting and costimulatory antibody programmes against solid tumors.
NILK-2301 Program
CEA x CD3 bispecific antibody in IND/CTA enabling, targeting CEACAM5-expressing solid tumors and advancing into Phase I study.
NILK-3301 Program
CEA x CD28 bispecific antibody in preclinical development for solid tumors, designed to provide a T-cell costimulatory signal restricted by CEA on tumor cells.
Trust & reputation

ranQ Trust Score of LamKap Bio alpha AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

LamKap Bio alpha AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
LamKap Bio alpha AG scores 76.6 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.79.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
LamKap Bio alpha AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
LamKap Bio alpha AG scores 2.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.2.94%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

LamKap Bio alpha AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once LamKap Bio alpha AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

LamKap Bio alpha AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank LamKap Bio alpha AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of LamKap Bio alpha AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Bahnhofstrasse 1
8808 Pfäffikon Sz

At a glance

Legal form
Corporation
UID
CHE-239.079.203
Founded
2018 · 8 years
Last commercial register change
August 14, 2025
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    DM
    discoveric marina ag
    Pfäffikon Sz
    MG
    Medable GmbH
    Pfäffikon Sz
    DM
    discoveric marketplace ag
    Pfäffikon Sz
    LM
    LRE Medical Switzerland AG
    Pfäffikon Sz
    ZM
    Zircon Medical AG
    Altendorf
    PM
    Patent Medical AG
    Altendorf
    RG
    RSG-Europe GmbH
    Lachen Sz
    CL
    Charlie's Lab GmbH
    Wangen Sz